These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16217386)

  • 1. Modulation of mitogen-activated protein kinase cascades by differentiation-1 protein: acquired drug resistance of hormone independent prostate cancer cells.
    Lin JC; Chang SY; Hsieh DS; Lee CF; Yu DS
    J Urol; 2005 Nov; 174(5):2022-6. PubMed ID: 16217386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of Id-1, MIF and GSTpi with acquired drug resistance in hormone independent prostate cancer cells.
    Lin JC; Chang SY; Hsieh DS; Lee CF; Yu DS
    Oncol Rep; 2005 May; 13(5):983-8. PubMed ID: 15809768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of extracellular signal-regulated kinase/mitogen-activated protein kinase pathway in multidrug resistance of hepatocellular carcinoma].
    Zhu H; Chen XP; Luo SF; Guan J; Zhang WG; Zhang BX; Mao CP
    Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(13):917-20. PubMed ID: 17953842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
    Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
    Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of MDR-1 gene by MIF and GSTpi with drug resistance generation in hormone independent prostate cancer.
    Yu DS; Lin JC; Hsieh DS; Chang SY; Lee CF
    Arch Androl; 2006; 52(4):283-91. PubMed ID: 16728344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
    Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression and/or activation of P38MAPK, erk1/2, and jnk during the initiation and progression of prostate cancer.
    Uzgare AR; Kaplan PJ; Greenberg NM
    Prostate; 2003 May; 55(2):128-39. PubMed ID: 12661038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
    Yang R; Piperdi S; Gorlick R
    Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein tyrosine kinase, JNK, and ERK involvement in pseudolaric acid B-induced apoptosis of human breast cancer MCF-7 cells.
    Yu JH; Wang HJ; Li XR; Tashiro S; Onodera S; Ikejima T
    Acta Pharmacol Sin; 2008 Sep; 29(9):1069-76. PubMed ID: 18718176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Id-1-induced Raf/MEK pathway activation is essential for its protective role against taxol-induced apoptosis in nasopharyngeal carcinoma cells.
    Cheung HW; Ling MT; Tsao SW; Wong YC; Wang X
    Carcinogenesis; 2004 Jun; 25(6):881-7. PubMed ID: 14742319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitogen-activated protein kinase phosphatase-1 in human breast cancer independently predicts prognosis and is repressed by doxorubicin.
    Rojo F; González-Navarrete I; Bragado R; Dalmases A; Menéndez S; Cortes-Sempere M; Suárez C; Oliva C; Servitja S; Rodriguez-Fanjul V; Sánchez-Pérez I; Campas C; Corominas JM; Tusquets I; Bellosillo B; Serrano S; Perona R; Rovira A; Albanell J
    Clin Cancer Res; 2009 May; 15(10):3530-9. PubMed ID: 19417026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin induces apoptotic death in LNCaP cells via p38 and JNK pathways: therapeutic implications for prostate cancer.
    Joo SS; Yoo YM
    J Pineal Res; 2009 Aug; 47(1):8-14. PubMed ID: 19522739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing expression of GST-pi MIF, and ID1 genes in chemoresistant prostate cancer cells.
    Yu DS; Hsieh DS; Chang SY
    Arch Androl; 2006; 52(4):275-81. PubMed ID: 16728343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphatidylinositol 3'-kinase activation leads to multidrug resistance protein-1 expression and subsequent chemoresistance in advanced prostate cancer cells.
    Lee JT; Steelman LS; McCubrey JA
    Cancer Res; 2004 Nov; 64(22):8397-404. PubMed ID: 15548710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of mcl-1 by small interfering RNA sensitizes resistant melanoma cells to fas-mediated apoptosis.
    Chetoui N; Sylla K; Gagnon-Houde JV; Alcaide-Loridan C; Charron D; Al-Daccak R; Aoudjit F
    Mol Cancer Res; 2008 Jan; 6(1):42-52. PubMed ID: 18234961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
    Gulati AP; Yang YM; Harter D; Mukhopadhyay A; Aggarwal BB; Benzil DL; Whysner J; Albino AP; Murali R; Jhanwar-Uniyal M
    Mol Carcinog; 2006 Jan; 45(1):26-37. PubMed ID: 16267831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of Id-1 in prostate cancer cells promotes angiogenesis through the activation of vascular endothelial growth factor (VEGF).
    Ling MT; Lau TC; Zhou C; Chua CW; Kwok WK; Wang Q; Wang X; Wong YC
    Carcinogenesis; 2005 Oct; 26(10):1668-76. PubMed ID: 15905202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-redundant inhibitor of differentiation (Id) gene expression and function in human prostate epithelial cells.
    Asirvatham AJ; Schmidt MA; Chaudhary J
    Prostate; 2006 Jun; 66(9):921-35. PubMed ID: 16541417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saposin C stimulates growth and invasion, activates p42/44 and SAPK/JNK signaling pathways of MAPK and upregulates uPA/uPAR expression in prostate cancer and stromal cells.
    Koochekpour S; Sartor O; Hiraiwa M; Lee TJ; Rayford W; Remmel N; Sandhoff K; Minokadeh A; Patten DY
    Asian J Androl; 2005 Jun; 7(2):147-58. PubMed ID: 15897971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of extracellular signal-regulated kinase during silibinin-protected, isoproterenol-induced apoptosis in rat cardiac myocytes is tyrosine kinase pathway-mediated and protein kinase C-dependent.
    Zhou B; Wu LJ; Tashiro S; Onodera S; Uchiumi F; Ikejima T
    Acta Pharmacol Sin; 2007 Jun; 28(6):803-10. PubMed ID: 17506939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.